Both naturally produced GLP-1 and medication forms can cross the blood-brain barrier 27
Assuming a 10% GLP-1 usage rate among overweight adults and a 20% usage rate among obese adults in the U.S., Roe (2025) estimates this could lead to a 3% reduction in total caloric demand, which amounts to 20 billion fewer calories of food consumed per day and about $1.2 billion less spent per week
Cognitive, emotional and social factors are critical determinants of self-care behaviours and, consequently, treatment success [165, 166]
New England Journal of Medicine , 393 , 2636.
ColonBroom GLP-1 Booster is a dietary supplement, not a medication
Most studies have found a decrease in GLP-1 secretion in obese individuals [92], and some studies have found no difference in GLP-1 levels between obese and normal-weight controls [93]